Xiaodi Zhao

3.8k total citations · 1 hit paper
68 papers, 2.1k citations indexed

About

Xiaodi Zhao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaodi Zhao has authored 68 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 26 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Xiaodi Zhao's work include MicroRNA in disease regulation (16 papers), RNA modifications and cancer (15 papers) and Cancer-related molecular mechanisms research (13 papers). Xiaodi Zhao is often cited by papers focused on MicroRNA in disease regulation (16 papers), RNA modifications and cancer (15 papers) and Cancer-related molecular mechanisms research (13 papers). Xiaodi Zhao collaborates with scholars based in China, South Korea and United States. Xiaodi Zhao's co-authors include Daiming Fan, Yuanyuan Lu, Yongzhan Nie, Kaichun Wu, Yongquan Shi, Boda Wang, Ahui Fan, Xin Wang, Feng Du and Lina Sun and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Xiaodi Zhao

66 papers receiving 2.1k citations

Hit Papers

Immunotherapy in colorectal cancer: current achievements ... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodi Zhao China 24 1.5k 1.1k 467 231 206 68 2.1k
Mina Maftouh Iran 26 1.2k 0.8× 752 0.7× 648 1.4× 189 0.8× 197 1.0× 39 1.9k
Shoumin Zhu United States 22 1.5k 1.0× 1.2k 1.1× 351 0.8× 213 0.9× 175 0.8× 53 2.0k
Tiansong Xia China 30 1.6k 1.1× 1.2k 1.2× 458 1.0× 183 0.8× 170 0.8× 75 2.2k
Yueming Sun China 24 1.4k 0.9× 1.1k 1.1× 483 1.0× 266 1.2× 158 0.8× 77 2.0k
Longjuan Zhang China 27 1.4k 0.9× 860 0.8× 462 1.0× 149 0.6× 190 0.9× 55 2.0k
Kuo‐Tai Hua Taiwan 30 1.7k 1.2× 716 0.7× 492 1.1× 179 0.8× 293 1.4× 62 2.3k
Zebin Wang China 19 1.5k 1.0× 659 0.6× 692 1.5× 196 0.8× 182 0.9× 49 2.2k
Zhaodong Han China 26 1.2k 0.8× 704 0.7× 403 0.9× 414 1.8× 200 1.0× 76 1.8k
Masanobu Tsubaki Japan 31 1.2k 0.8× 660 0.6× 848 1.8× 206 0.9× 194 0.9× 93 2.2k

Countries citing papers authored by Xiaodi Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaodi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodi Zhao more than expected).

Fields of papers citing papers by Xiaodi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodi Zhao. The network helps show where Xiaodi Zhao may publish in the future.

Co-authorship network of co-authors of Xiaodi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodi Zhao. A scholar is included among the top collaborators of Xiaodi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodi Zhao. Xiaodi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shuyi, Tingyu Li, Dan Liu, et al.. (2025). Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer. Oncogene. 44(25). 2064–2077. 3 indexed citations
2.
Wang, Haojia, Songtao Ji, Xuemei Li, et al.. (2025). SMARCA1-NPFF axis inhibits colorectal cancer metastasis by blocking epithelial-mesenchymal transition and macrophage-dependent immune reprogramming. Cancer Letters. 631. 217933–217933. 1 indexed citations
4.
Liu, Hao, et al.. (2024). Neutrophils in cancer drug resistance: Roles and therapeutic opportunities. Cancer Letters. 611. 217417–217417. 3 indexed citations
5.
Wu, Kaichun, et al.. (2024). Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants. Cancer Biology and Medicine. 21(6). 473–483. 6 indexed citations
6.
Ji, Songtao, Haojia Wang, Ang Li, et al.. (2024). The current role of dendritic cells in the progression and treatment of colorectal cancer. Cancer Biology and Medicine. 21(9). 1–15. 10 indexed citations
7.
Wang, Pei, Juan Wang, Yun Zhou, et al.. (2024). miR-107 reverses the multidrug resistance of gastric cancer by targeting the CGA/EGFR/GATA2 positive feedback circuit. Journal of Biological Chemistry. 300(8). 107522–107522. 3 indexed citations
8.
Shi, Xiaohu, Yingda Zang, Xiaodi Zhao, et al.. (2023). 7-hydroxycoumarin-β-D-glucuronide protects against cisplatin-induced acute kidney injury via inhibiting p38 MAPK-mediated apoptosis in mice. Life Sciences. 327. 121864–121864. 11 indexed citations
9.
An, Guangzhou, et al.. (2023). Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers. Cancer Biology and Medicine. 20(8). 1–24. 4 indexed citations
10.
Zhao, Xiaodi, et al.. (2023). Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron. Nutrients. 15(22). 4774–4774. 4 indexed citations
11.
Tan, Xiangyu, Yuting Li, Huahui Li, et al.. (2023). WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer. Oncogene. 42(41). 3062–3074. 23 indexed citations
12.
Ahn, Do-Hee, et al.. (2022). Structure–Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition. International Journal of Molecular Sciences. 23(7). 3927–3927. 6 indexed citations
13.
Ahn, Do-Hee, et al.. (2022). Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects. International Journal of Molecular Sciences. 23(9). 5020–5020. 19 indexed citations
14.
Zhang, Xiaohui, Tingyu Li, Yanan Han, et al.. (2021). miR-125b Promotes Colorectal Cancer Migration and Invasion by Dual-Targeting CFTR and CGN. Cancers. 13(22). 5710–5710. 27 indexed citations
15.
Wang, Xin, Lina Sun, Hao Liu, et al.. (2020). Regulation of the small GTPase Ran by miR-802 modulates proliferation and metastasis in colorectal cancer cells. British Journal of Cancer. 122(11). 1695–1706. 13 indexed citations
16.
Sun, Lina, Ying Fang, Xin Wang, et al.. (2019). miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44. Theranostics. 9(26). 8409–8425. 74 indexed citations
17.
Liu, Hao, Feng Du, Lina Sun, et al.. (2019). GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer. Cell Death and Disease. 10(2). 31 indexed citations
18.
Lei, Chao, Feng Du, Lina Sun, et al.. (2017). miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death and Disease. 8(10). e3101–e3101. 112 indexed citations
19.
Li, Ting, Hanqing Guo, Xiaodi Zhao, et al.. (2016). Gastric Cancer Cell Proliferation and Survival Is Enabled by a Cyclophilin B/STAT3/miR-520d-5p Signaling Feedback Loop. Cancer Research. 77(5). 1227–1240. 41 indexed citations
20.
Lu, Yuanyuan, Xiaodi Zhao, Guanhong Luo, et al.. (2014). Thioredoxin-like protein 2b facilitates colon cancer cell proliferation and inhibits apoptosis via NF-κB pathway. Cancer Letters. 363(2). 119–126. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026